Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.
about
Procarbazine, lomustine and vincristine for recurrent high-grade gliomaMalignant gliomas: current perspectives in diagnosis, treatment, and early response assessment using advanced quantitative imaging methodsRadioactive (125)I seeds inhibit cell growth and epithelial-mesenchymal transition in human glioblastoma multiforme via a ROS-mediated signaling pathwayMetabotropic glutamate receptors as a new therapeutic target for malignant gliomasFluorescence-guided surgery and biopsy in gliomas with an exoscope system.Conditioned media from human adipose tissue-derived mesenchymal stem cells and umbilical cord-derived mesenchymal stem cells efficiently induced the apoptosis and differentiation in human glioma cell lines in vitroGαi3 nuclear translocation causes irradiation resistance in human glioma cells.Evolution of malignant glioma treatment: from chemotherapy to vaccines to viruses.Abundant kif21b is associated with accelerated progression in neurodegenerative diseases.RNA-seq of 272 gliomas revealed a novel, recurrent PTPRZ1-MET fusion transcript in secondary glioblastomas.Engineering toxin-resistant therapeutic stem cells to treat brain tumorsGlioma-derived plasminogen activator inhibitor-1 (PAI-1) regulates the recruitment of LRP1 positive mast cells.Prognostic value of a nine-gene signature in glioma patients based on mRNA expression profiling.Oncostatin-M differentially regulates mesenchymal and proneural signature genes in gliomas via STAT3 signaling.Prevalence and clinicopathologic characteristics of the molecular subtypes in malignant glioma: a multi-institutional analysis of 941 casesAn axis involving SNAI1, microRNA-128 and SP1 modulates glioma progression.Tetraspanin 8-rictor-integrin α3 complex is required for glioma cell migration.LRIG1 enhances the radiosensitivity of radioresistant human glioblastoma U251 cells via attenuation of the EGFR/Akt signaling pathway.HOTAIR is a therapeutic target in glioblastoma.ROS-p53-cyclophilin-D signaling mediates salinomycin-induced glioma cell necrosismicroRNA-153 Targets mTORC2 Component Rictor to Inhibit Glioma CellsGSK1838705A, an IGF-1R inhibitor, inhibits glioma cell proliferation and suppresses tumor growth in vivo.GSK621 Targets Glioma Cells via Activating AMP-Activated Protein Kinase SignalingsGab3 overexpression in human glioma mediates Akt activation and tumor cell proliferation.CD147 and glioma: a meta-analysis.Identification of high risk anaplastic gliomas by a diagnostic and prognostic signature derived from mRNA expression profiling.Single agent efficacy of the VEGFR kinase inhibitor axitinib in preclinical models of glioblastomaThe Impact of Macrophage- and Microglia-Secreted TNFα on Oncolytic HSV-1 Therapy in the Glioblastoma Tumor MicroenvironmentBMP4, a strong better prognosis predictor, has a subtype preference and cell development association in gliomasImatinib and Nilotinib increase glioblastoma cell invasion via Abl-independent stimulation of p130Cas and FAK signalling.KIF23 is an independent prognostic biomarker in glioma, transcriptionally regulated by TCF-4.HOTAIR, a cell cycle-associated long noncoding RNA and a strong predictor of survival, is preferentially expressed in classical and mesenchymal glioma.Epigenetic modification of miR-141 regulates SKA2 by an endogenous 'sponge' HOTAIR in glioma.miR-92a-3p Exerts Various Effects in Glioma and Glioma Stem-Like Cells Specifically Targeting CDH1/β-Catenin and Notch-1/Akt Signaling Pathways.Phosphohistone H3 (pHH3) is a prognostic and epithelial to mesenchymal transition marker in diffuse gliomas.Identification of a five B cell-associated gene prognostic and predictive signature for advanced glioma patients harboring immunosuppressive subtype preference.LncRNAs: new players in gliomas, with special emphasis on the interaction of lncRNAs With EZH2.Rindopepimut: a promising immunotherapeutic for the treatment of glioblastoma multiforme.MicroRNA-7 directly targets insulin-like growth factor 1 receptor to inhibit cellular growth and glucose metabolism in gliomasWhole-genome mRNA expression profiling identifies functional and prognostic signatures in patients with mesenchymal glioblastoma multiforme.
P2860
Q24187436-B7ADE940-A164-46F4-94BF-C042D8A20C1BQ26853516-CDBC9B9F-316C-42E3-91F3-1730F86D7900Q28393939-752D6641-ABBF-44E0-A493-80F8C8132025Q33591900-A2D77BA0-CD3C-4946-98A7-7AC39DB6ADEEQ33747371-905950DD-CB32-4FE8-9EAE-B50EDC175C71Q33757933-9EC83092-005D-47B9-BD7E-7B9178989388Q33798731-12B98459-CFB7-4E4E-96B7-484DF80B5CEEQ33923950-B1E5641F-FA8E-446E-89CD-4C6141A345DCQ34392911-4354873B-6FA6-4C77-AA2A-EAAC30FC2A8EQ34439333-C5833AAF-C877-458B-91CB-9786B7D091B5Q34444939-13D7F66A-A8C5-4151-925B-23F713F1B77EQ34484456-01AA2A7D-0C41-4737-8FDB-51A2ABC987B0Q35054380-698AA036-B241-48EB-96C4-121758EBCECDQ35152569-6A2D7BCE-8E82-452E-B4D1-3CFB21CD1B37Q35154801-A662E91B-9B86-414D-AC0D-315868ADBF03Q35193962-36375605-A64E-4288-81DD-7629D10DD897Q35381006-63B6F6A8-5825-4505-BCB7-0D95AF488988Q35740934-63336F5C-B541-4598-86E3-28DFAEA96BC4Q35781595-451C9F7F-A68E-40C8-B539-8E65793C06F9Q35801577-4F3F14CE-7BBB-4CBF-BC3F-90FE2DE72F5CQ36050424-1E7B8BF0-17AC-4754-9424-EEE7369CE613Q36089874-BEE64670-E842-4686-93FD-EABF18393971Q36105554-3D0330C6-FCBF-4F84-BD35-4CF6AE5497A2Q36307539-5A1F445B-20E1-430F-B54E-6F2F5C40E0FFQ36385821-CD2F3537-0757-45DB-907F-3DAF88D6D823Q36546750-944100B6-8553-4D90-B4FA-28BD98744792Q36575238-7D9363AD-D8B7-4E5F-B025-6F8A1F3FF93AQ36658280-74C43914-CCE9-473B-AA44-E148A5105BE2Q36798613-9A05BB71-EAF4-4EC0-9308-799C12657352Q36996552-AE2A31EF-9A54-49F7-9907-12463250D4FEQ37269393-A9A1400C-9D34-4EB5-ADB1-288D877CFFE2Q37312737-CBA0D759-6D9B-49DD-A892-38FAE6E6A6E8Q37327566-3C706845-B417-4B01-B441-F7ABAEDD7119Q37465382-68E9CB79-7A11-4478-9A7C-790515677434Q37564326-09F66B05-7102-40FB-88FC-E386B441A197Q37687506-1C271D2D-904D-4C2B-9885-3947713FF5E4Q38176848-D6DEB11C-2295-4957-B4AC-70F394BB2160Q38245925-ACA70910-3838-49A4-9178-8DBCEAEF13D0Q38303084-22DAEA91-8D84-4590-A5C4-6DAA5458AFDAQ38439155-64CC5197-1187-4CF5-986A-4461D44AD6CA
P2860
Understanding high grade glioma: molecular mechanism, therapy and comprehensive management.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Understanding high grade gliom ...... and comprehensive management.
@en
type
label
Understanding high grade gliom ...... and comprehensive management.
@en
prefLabel
Understanding high grade gliom ...... and comprehensive management.
@en
P1433
P1476
Understanding high grade gliom ...... and comprehensive management.
@en
P2093
Yongzhi Wang
P304
P356
10.1016/J.CANLET.2012.12.024
P407
P577
2013-01-20T00:00:00Z